Zydus gets USFDA tentative nod for Empagliflozin Tablets Medical Dialogues Bureau11 April 2020 6:47 AM GMTAhmedabad: Zydus Cadila has received tentative approval from the USFDA to market Empagliflozin Tablets, in the strengths of 10 mg and 25 mg (US RLD:...
Zydus gets USFDA nod for Lamotrigine Extended-Release Tablets for seizures Medical Dialogues Bureau3 April 2020 8:02 AM GMTAhmedabad: Zydus Cadila has received final approval from the USFDA to market Lamotrigine Extended-Release Tablets USP in the strengths of 25 mg, 50...
Zydus gets USFDA tentative nod for Carbidopa, Levodopa Extended-Release Capsules Medical Dialogues Bureau31 March 2020 8:00 AM GMTAhmedabad: Zydus Cadila has received tentative approval from the USFDA to market Carbidopa and Levodopa Extended-Release Capsules in the strengths of...
Cadila Healthcare BOD approves transfer of Animal Healthcare Business to Zydus Animal Health and Investments Limited Medical Dialogues Bureau15 March 2020 3:30 AM GMTNew Delhi: Cadila Healthcare Ltd. has recently announced that the Board of Directors at its meeting, has approved the transfer of Animal Healthcare...
Zydus, XOMA enter into licensing agreement for IL-2-Based Immuno-Oncology Therapy Medical Dialogues Bureau11 March 2020 3:30 AM GMTAhmedabad, Emeryville: Zydus Cadila and XOMA Corporation have announced they have entered into a licensing agreement to advance an IL-2-based...
Zydus gets DCGI nod for Phase I clinical trial of ZYBK2b to treat Rheumatoid Arthritis Medical Dialogues Bureau4 March 2020 5:04 AM GMTZYBK2 has been specifically designed to inhibit HLA-DRB1 Shared Epitope (SE) that determines the susceptibility of a person to develop rheumatoid...
Prices of Paracetamol surge by 40pc as coronavirus shuts China Farhat Nasim18 Feb 2020 7:51 AM GMTPrices of paracetamol, the most commonly used analgesic, have jumped by 40% in India, while the cost of azithromycin, an antibiotic used for treating...
Zydus Cadila announces research Program to develop Coronavirus Vaccine Medical Dialogues Bureau17 Feb 2020 9:26 AM GMTZydus has two state-of-the-art R&D Centres, one located in Catania, Italy and the other in Ahmedabad, in the western part of India
Zydus Cadila gets USFDA nod for bowel disease drug Mesalamine suppositories Farhat Nasim13 Feb 2020 7:34 AM GMT"Zydus Cadila has received the final approval from the USFDA to market Mesalamine Suppositories for rectal use...1000 mg," the drug firm said in a...
Zydus Cadila gets USFDA nod for Fluocinonide cream to treat skin conditions Medical Dialogues Bureau12 Feb 2020 7:21 AM GMTFluocinonide cream USP, 0.1 per cent, approved by USFDA is indicated to treat a variety of skin conditions such as psoriasis, eczema, dermatitis,...
Zydus Cadila unveils affordable anti-diabetic drug Vildagliptin under brands Vinglyn, Vinglyn M Medical Dialogues Bureau12 Dec 2019 6:23 AM GMTAhmedabad: With the Novartis Blockbuster Vildagliptin going off patent, Zydus Cadila has taken made its move towards affordable diabetes care in India...
Zydus Cadila receives warning letter from USFDA for Moraiya-based formulation facility Medical Dialogues Bureau5 Nov 2019 7:27 AM GMTNew Delhi: Drug firm Zydus Cadila on Monday said it has received a warning letter from the US health regulator for its Moraiya-based formulation...